Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study).


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
06 2022
Historique:
received: 19 01 2022
accepted: 16 03 2022
pubmed: 22 4 2022
medline: 22 6 2022
entrez: 21 4 2022
Statut: ppublish

Résumé

Severely ill patients affected by coronavirus disease 2019 (COVID-19) develop circulatory failure. We aimed to report patterns of left and right ventricular dysfunction in the first echocardiography following admission to intensive care unit (ICU). Retrospective, descriptive study that collected echocardiographic and clinical information from severely ill COVID-19 patients admitted to 14 ICUs in 8 countries. Patients admitted to ICU who received at least one echocardiography between 1st February 2020 and 30th June 2021 were included. Clinical and echocardiographic data were uploaded using a secured web-based electronic database (REDCap). Six hundred and seventy-seven patients were included and the first echo was performed 2 [1, 4] days after ICU admission. The median age was 65 [56, 73] years, and 71% were male. Left ventricle (LV) and/or right ventricle (RV) systolic dysfunction were found in 234 (34.5%) patients. 149 (22%) patients had LV systolic dysfunction (with or without RV dysfunction) without LV dilatation and no elevation in filling pressure. 152 (22.5%) had RV systolic dysfunction. In 517 patients with information on both paradoxical septal motion and quantitative RV size, 90 (17.4%) had acute cor pulmonale (ACP). ACP was associated with mechanical ventilation (OR > 4), pulmonary embolism (OR > 5) and increased PaCO Almost one-third of this cohort of critically ill COVID-19 patients exhibited abnormal LV and/or RV systolic function in their first echocardiography assessment. While LV systolic dysfunction appears similar to septic cardiomyopathy, RV systolic dysfunction was related to pressure overload due to positive pressure ventilation, hypercapnia and pulmonary embolism. ACP and age seemed to be associated with mortality in this cohort.

Identifiants

pubmed: 35445822
doi: 10.1007/s00134-022-06685-2
pii: 10.1007/s00134-022-06685-2
pmc: PMC9022062
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-678

Investigateurs

Anne-Marie Welsh (AM)
H Didriksson (H)
Yoann Zerbib (Y)
Clément Brault (C)
Laetitia Bodénes (L)
Nicolas Ferrière (N)
S Clavier (S)
I Ma (I)
Luigi La Via (L)
Veronica Dezio (V)
J B Rius (JB)
J R Palomares (JR)
Fernando Piscioneri (F)
S Giglioli (S)
S Banauch-Mayer (S)
Bruno François (B)
Anne-Laure Fedoux (AL)
Thomas Daix (T)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Michard F, Vieillard-Baron A (2021) Critically-ill patients with COVID-19: are they hemodynamically unstable and do we know why? Intensive Care Med 47(2):254–255
doi: 10.1007/s00134-020-06238-5
Zhou F, Yu T, Fan G, Liu Z, Xiang J, Wang Y et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062
doi: 10.1016/S0140-6736(20)30566-3
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA Cardiol 5(7):802–810
doi: 10.1001/jamacardio.2020.0950
Hendren N, Drazner M, Bozkurt B, Cooper L (2020) Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 141:1903–1914
doi: 10.1161/CIRCULATIONAHA.120.047349
Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19. A prospective cohort study. Ann Intern Med 173(4):268–277
doi: 10.7326/M20-2003
Gattinoni L, Chiumello D, Caironi P, Busana M, Rominiti F, Brazzi L et al (2020) COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46(6):1099–1102
doi: 10.1007/s00134-020-06033-2
Mekontso-Dessap A, Boissier F, Charron C, Bégot E, Repessé X, Legras A et al (2016) Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med 42:862–870
doi: 10.1007/s00134-015-4141-2
Topol EJ (2020) COVID-19 can affect the heart. Science 370(6515):408–409
doi: 10.1126/science.abe2813
Dweck M, Bularga A, Hahn R, Bing R, Lee KK, Chapman AR et al (2020) Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging 21(9):949–958
doi: 10.1093/ehjci/jeaa178
Sanfilippo F, Huang S, Herpain A, Balik M, Chew M, Clau-Terré F et al (2021) The PRICES statement: an ESICM expert consensus on methodology for conducting and reporting critical care echocardiography research studies. Intensive Care Med 47(1):1–13
doi: 10.1007/s00134-020-06262-5
Doyen D, Dupland P, Morand L, Fourrier E, Saccheri C, Buscot M et al (2021) Characteristics of cardiac injury in critically ill patients with coronavirus disease 2019. Chest 159(5):1974–1985
doi: 10.1016/j.chest.2020.10.056
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-COV-2 admitted to ICUs of the Lombardy region. Italy JAMA 323(16):1574–1581
doi: 10.1001/jama.2020.5394
COVID-ICU group on behalf of the REVA network and the COVID-ICU investigators (2021) Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 47(1):60–73
doi: 10.1007/s00134-020-06294-x
Vieillard-Baron A, Prin S, Chergui K, Dubourg O, Jardin F (2003) Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 168(11):1270–1276
doi: 10.1164/rccm.200306-816CC
Kox M, Waalders N, Kooistra E, Gerretsen J, Pickkers P (2020) Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA 324(15):1565–1567
doi: 10.1001/jama.2020.17052
Del Valle D, Kim-Schulze S, Huang H, Beckmann N, Nirenberg S, Wang B et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26(10):1636–1643
doi: 10.1038/s41591-020-1051-9
Nagueh SF, Smiseth OA, Appleton CP, Byrd B, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360
doi: 10.1093/ehjci/jew082
Hollenberg S, Safi L, Parrillo J, Fata M, Klinkhammer B, Gayed N et al (2021) Hemodynamic profiles of shock in patients with COVID-19. Am J Cardiol 153:135–139
doi: 10.1016/j.amjcard.2021.05.029
Vieillard-Baron A, Prin S, Chergui K, Dubourg O, Jardin F (2002) Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med 166(10):1310–1319
doi: 10.1164/rccm.200202-146CC
Evrard B, Goudelin M, Montmagnon N, Fedou A, Lafon T, Vignon P (2020) Cardiovascular phenotypes in ventilated patients with COVID-19 acute respiratory distress syndrome. Crit Care 24(1):236
doi: 10.1186/s13054-020-02958-8
Kim J, Volodarskiy A, Sultan R, Pollie MP, Yum B, Nambiar L et al (2020) Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19. J Am Coll Cardiol 76(17):1965–1977
doi: 10.1016/j.jacc.2020.08.066
Bleakley C, Singh S, Garfield B, Morosin M, Surkova E, Mandalia S, Dias B, Androulakis E, Proce LC, McCabe C, Wort SJ, West C, Li W, Khattar R, Senior R, Patel BV, Price S (2021) Right ventricular dysfunction in critically illCOVID-19 ARDS. Int J Cardiol 327:251–258
doi: 10.1016/j.ijcard.2020.11.043
Cavaleiro P, Masi P, Bagate F, d’Humières T, Mekontso-Dessap A (2021) Acute cor pulmonale in COVID-19 related acute respiratory distress syndrome. Crit Care 25(1):346
doi: 10.1186/s13054-021-03756-6
Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis thrombosis and angiogenesis in COVID-19. N Engl J Med 383(2):120–128
doi: 10.1056/NEJMoa2015432
Archer S, Sharp W, Weir E (2020) Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications. Circulation 142(2):101–104
doi: 10.1161/CIRCULATIONAHA.120.047915
Caravita S, Baratto C, Di Marco F, Calabrese A, Balestrieri G, Russo F et al (2020) Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization. Eur J Heart Fail 22(12):228–2237
doi: 10.1002/ejhf.2058
Soulat-Dufour L, Fauvel C, Weizman O, Barbe T, Pezel T, Mika D et al (2021) Prognostic value of right ventricular dilatation in patients with COVID-19: a multicenter study. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jeab067
doi: 10.1093/ehjci/jeab067 pubmed: 33709114
Silverio A, Di Maio M, Scudiero F, Russo V, Esposito L, Attena E et al (2021) Clinical conditions and echocardiographic parameters associated with mortality in COVID-19. Eur J Clin Invest 51:e13638
doi: 10.1111/eci.13638

Auteurs

Stephen Huang (S)

Intensive Care Medicine, Nepean Hospital, The University of Sydney, Sydney, Australia.

Philippe Vignon (P)

Medical-Surgical ICU, Dupuytren Teaching Hospital, Inserm CIC 1435 and UMR 1092, 87000, Limoges, France.

Armand Mekontso-Dessap (A)

Service de Médecine Intensive Réanimation, Hôpitaux universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Groupe de Recherche Clinique CARMAS, Inserm U955, Université Paris-Est Créteil, 94000, Créteil, France.

Ségolène Tran (S)

Service de Médecine Intensive Réanimation, Assistance Publique-Hôpitaux de Paris, University Hospital Ambroise Paré, 92100, Boulogne-Billancourt, France.

Gwenael Prat (G)

Service de Médecine Intensive Réanimation, CHU Cavale Blanche Brest, Brest, France.

Michelle Chew (M)

Department of Anaesthesiology and Intensive Care, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Martin Balik (M)

Department of Anesthesiology and Intensive Care, General University Hospital and 1st Medical Faculty, Charles University, Prague, Czechia.

Filippo Sanfilippo (F)

Department of Anesthesia and Intensive Care, Policlinico-Vittorio Emanuele University Hospital, Catania, Italy.

Gisele Banauch (G)

Division of Pulmonary, Critical Care and Allergy, Department of Medicine, UmassMemorial Medical Center, The University Hospital for University of Massachusetts, Worcester, MA, USA.

Fernando Clau-Terre (F)

Department of Anaesthesiology and Critical Care Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.

Andrea Morelli (A)

Department Clinical Internal, Anesthesiological and Cardiovascular Sciences, University of Rome, "La Sapienza", Policlinico Umberto Primo, Viale del Policlinico, Rome, Italy.

Daniel De Backer (D)

CHIREC Hospitals, Université Libre de Bruxelles, Brussels, Belgium.

Bernard Cholley (B)

Department of Anesthesiology and Critical Care Medicine, Hôpital Européen Georges Pompidou, AP-HP and Université de Paris, 20 Rue Leblanc, 75015, Paris, France.

Michel Slama (M)

Medical Intensive Care Unit, Amiens University Hospital, Amiens, France.

Cyril Charron (C)

Service de Médecine Intensive Réanimation, Assistance Publique-Hôpitaux de Paris, University Hospital Ambroise Paré, 92100, Boulogne-Billancourt, France.

Marine Goudelin (M)

Medical-Surgical ICU, Dupuytren Teaching Hospital, Inserm CIC 1435 and UMR 1092, 87000, Limoges, France.

Francois Bagate (F)

Service de Médecine Intensive Réanimation, Hôpitaux universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Groupe de Recherche Clinique CARMAS, Inserm U955, Université Paris-Est Créteil, 94000, Créteil, France.

Pierre Bailly (P)

Service de Médecine Intensive Réanimation, CHU Cavale Blanche Brest, Brest, France.

Patrick-Johansson Blixt (PJ)

Department of Anaesthesiology and Intensive Care, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Paul Masi (P)

Service de Médecine Intensive Réanimation, Hôpitaux universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, Groupe de Recherche Clinique CARMAS, Inserm U955, Université Paris-Est Créteil, 94000, Créteil, France.

Bruno Evrard (B)

Medical-Surgical ICU, Dupuytren Teaching Hospital, Inserm CIC 1435 and UMR 1092, 87000, Limoges, France.

Sam Orde (S)

Intensive Care Medicine, Nepean Hospital, The University of Sydney, Sydney, Australia.

Paul Mayo (P)

Division of Pulmonary, Critical Care and Sleep Medicine, Northwell Health LIJ/NSUH Medical Center, Zucker School of Medicine, Hofstra/Northwell, Hempstead, NY, USA.

Anthony S McLean (AS)

Intensive Care Medicine, Nepean Hospital, The University of Sydney, Sydney, Australia.

Antoine Vieillard-Baron (A)

Service de Médecine Intensive Réanimation, Assistance Publique-Hôpitaux de Paris, University Hospital Ambroise Paré, 92100, Boulogne-Billancourt, France. antoine.vieillard-baron@aphp.fr.
INSERM, UMR 1018, Clinical Epidemiology Team, CESP, Université de Paris Saclay, Villejuif, France. antoine.vieillard-baron@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH